CPT code 0202U designates a Proprietary Laboratory Analyses (PLA) test for the BioFire® FilmArray® Respiratory Panel 2.1 (RP2.1), an automated PCR assay on nasopharyngeal specimens that detects the most common viral and bacterial respiratory pathogens, including SARS–CoV–2. As a PLA code, 0202U applies to a single manufacturer-specific test, which affects coding clarity and payer adjudication across the country. Nationally, the code matters because respiratory multiplex PCR panels play a key role in diagnostic workflows, infection control, and public health surveillance, especially during respiratory virus seasons and pandemic response.

Key payers examined include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose and service setting for the test, payer coverage landscape, and typical billing context for a PLA code. The publication outlines reimbursement benchmarks, common modifier usage, and coding considerations relevant to laboratory and hospital billing teams. It also provides clinical context for when a multiplex respiratory PCR panel is used and summarizes policy points that influence payment and claims processing. Data not available in the input is noted where applicable.